Kestra Advisory Services, LLC Guardant Health, Inc. Transaction History

Kestra Advisory Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$25.44 - $59.78 $22,845 - $53,682	-898 Reduced 7.25%	11,491 $312,000
Q3 2022 Nov 01, 2022	BUY	$43.66 - $61.0 $17,114 - $23,912	392 Added 3.27%	12,389 $667 Million
Q2 2022 Aug 12, 2022	BUY	$28.82 - $77.35 $24,324 - $65,283	844 Added 7.57%	11,997 $484,000
Q1 2022 Apr 26, 2022	SELL	$48.25 - $100.49 $133,700 - $278,457	-2,771 Reduced 19.9%	11,153 $738,000
Q4 2021 Jan 20, 2022	SELL	$88.71 - $120.43 $228,250 - $309,866	-2,573 Reduced 15.6%	13,924 $1.39 Million
Q3 2021 Oct 19, 2021	SELL	$98.77 - $132.17 $128,203 - $171,556	-1,298 Reduced 7.29%	16,497 $2.06 Million
Q2 2021 Jul 28, 2021	BUY	$109.77 - $165.68 $433,591 - $654,436	3,950 Added 28.53%	17,795 $2.21 Million
Q1 2021 May 10, 2021	BUY	$127.04 - $179.1 $1.76 Million - $2.48 Million	13,845 New	13,845 $2.11 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.